Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | 0 | reported | 18 Nov 2024 | tx 22+543,166−116,535 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2024 | SALE | Syros Pharmaceuticals, Inc. | 36,133 | 0.22 USD | |
| 31 Oct 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6,104 | 2.09 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | — | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 01 Apr 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4,218 | 5.12 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11,666 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 11,666 | 0.00 USD | deriv |
| 01 Nov 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 5,676 | 2.22 USD | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | — | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 03 Apr 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 06 Oct 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 34,000 | 0.00 USD | deriv |
| 06 Oct 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 44,500 | 0.00 USD | deriv |
| 01 Apr 2022 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 14,115 | 1.12 USD | |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 80,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |